Ito, Yasuhiko http://orcid.org/0000-0002-9676-6961
Ryuzaki, Munekazu
Sugiyama, Hitoshi
Tomo, Tadashi
Yamashita, Akihiro C.
Ishikawa, Yuichi
Ueda, Atsushi
Kanazawa, Yoshie
Kanno, Yoshihiko
Itami, Noritomo
Ito, Minoru
Kawanishi, Hideki
Nakayama, Masaaki
Tsuruya, Kazuhiko
Yokoi, Hideki
Fukasawa, Mizuya
Terawaki, Hiroyuki
Nishiyama, Kei
Hataya, Hiroshi
Miura, Kenichiro
Hamada, Riku
Nakakura, Hyogo
Hattori, Motoshi
Yuasa, Hidemichi
Nakamoto, Hidetomo
Funding for this research was provided by:
Japanese Society of Dialysis Therapy (Not applicable)
Article History
Received: 2 January 2021
Accepted: 7 February 2021
First Online: 13 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: YI receives research funding, lecture fees, and other remuneration from or belongs to a department endowed by Baxter, Chugai Pharmaceutical Co., Kyowa Kirin Co., Novartis, and Teijin Pharma Ltd.MR receives travel expenses for participating in academic conferences and other events from OMRON Corp.HS receives research funding from Sumitomo Dainippon Pharma Co., Genzyme Corp., and Bayer Yakuhin Ltd.AY receives research funding, travel expenses for academic conferences and other events, and consultant fees from Nikkiso Co., Asahi Kasei Medical Co., and Nipro Corp.YK receives research funding, lecture fees, and writing fees from Kyowa Kirin Co., Chugai Pharmaceutical Co., Kissei Pharmaceutical Co., Torii Pharmaceutical Co., Sumitomo Dainippon Pharma Co., Merck Sharp & Dohme Corp., and Igaku-Shoin Ltd.NI receives lecture fees and other remuneration from Kyowa Kirin Co., Kissei Pharmaceutical Co., and Otsuka Pharmaceutical Co.HK receives lecture fees and other remuneration from Bayer Yakuhin Ltd., Kissei Pharmaceutical Co., Terumo Corp., Kyowa Kirin Co., Nipro Corp., and Chugai Pharmaceutical Co.MN receives research funding, lecture fees, writing fees, consultant fees, and other remuneration from Torii Pharmaceutical Co., Pureron Japan Co., Alpha Electron Co., Japan Tobacco Inc., Nikkiso Co., Torii Pharmaceutical Co., Baxter, Chugai Pharmaceutical Co., and Nihon Trim Co.KT receives research funding, lecture fees, and other remuneration from or belongs to a department endowed by Chugai Pharmaceutical Co., Kyowa Kirin Co., Torii Pharmaceutical Co., Baxter, Sanofi KK, and Takeda Pharmaceutical Co.HY receives research funding from Daiichi Sankyo Co., Baxter, and Mitsubishi Tanabe Pharma Corp.MF receives research funding from Nipro Corp., Baxter, Nikkiso Co., and Terumo Corp.HT receives research funding from Sanwa Kagaku Kenkyusho Co.HN receives research funding, lecture fees, writing fees, and other remuneration from Toray Industries Inc., Kissei Pharmaceutical Co., Boehringer Ingelheim International GmbH, Terumo Corp., Astellas Pharma Inc., JCR Pharmaceuticals Co., Kyowa Kirin Co., and Chugai Pharmaceutical Co.Y Ishikawa, AU, YK, MI, MH, KN, HH, KM and RH have no COI to declare.